Analysis of macrolide-lincosamide-streptogramin B (MLSB) resistance determinant in strains of Clostridium difficile

被引:17
|
作者
Spigaglia, P [1 ]
Mastrantonio, P [1 ]
机构
[1] Ist Super Sanita, Lab Bacteriol & Med Mycol, I-00161 Rome, Italy
关键词
D O I
10.1089/10766290252913755
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The macrolide-lincosamide-streptogramin B (MLSB) resistance determinants have been detected among Clostridia in both C perfringens and C difficile strains. Previous studies have shown that MLSB-resistant C difficile strains can be differentiated by specific hybridizing bands using an erm(B) probe. A recent study has demonstrated that C difficile 630, a strain highly resistant to clindamycin and erythromycin (MIC greater than or equal to 256 ml/L), showing a hybridizing band at 9.7 kb, contains two copies of an erm(B) gene. It was also hypothesized that C difficile 630 erm(B) determinant has arisen from a progenitor, represented by the C. perfringens CP592 determinant, which contains only one copy of an erm(B) gene that differs from C. difficile 630 erm(B) for seven nucleotide substitutions. To investigate the possibility that C. difficile strains with hybridizing fragments of different molecular size have an erm(B) determinant not identical to the one described in C. difficile 630, we performed a genetic analysis on the erm(B) determinant in 18 C. difficile strains, isolated from different sources. The results showed a heterogeneity in erm(B) determinant: C. difficile strains with hybridizing bands at 7.3 or 3.7 kb contained only one erm(B) copy, whereas strains with a band at 9.7 kb had two copies. The majority of the toxigenic strains examined was characterized by only one erm(B) copy with a sequence identical to the one found in C. difficile 630 and a lower resistance level for erythromycin (MICs ranging from 16 to 24 ml/L). Differently, some strains had an erm(B) gene identical to the one found in C. perfringens CP592. PCR ribotyping and clustering analysis indicate that the examined resistant strains, except one, belong to the same genetic lineage. These results seem to support the hypothesis of the evolution of the C. difficile 630 erm(B) determinant. The functional significance of one or two copies of erm(B) gene in C. difficile strains should be further investigated.
引用
收藏
页码:45 / 53
页数:9
相关论文
共 50 条
  • [1] INVESTIGATION OF MACROLIDE-LINCOSAMIDE-STREPTOGRAMIN B (MLSB) AND TELITHROMYCIN RESISTANCE IN CLINICAL STRAINS OF STAPHYLOCOCCI
    Saribas, Zeynep
    Tunckanat, Ferda
    Ozcakir, Olcay
    Ercis, Serpil
    [J]. MIKROBIYOLOJI BULTENI, 2010, 44 (02): : 177 - 186
  • [2] Macrolide-Lincosamide-Streptogramin B (Mlsb) Resistance Phenotype in Staphylococcal Isolates
    Yasar, Kadriye Kart
    Bilir, Yesim Aybar
    Pehlivanoglu, Filiz
    Gursoy, Sevtap
    Sengoz, Gonul
    [J]. HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, 2011, 49 (03): : 102 - 104
  • [3] Prevalence and association of macrolide-lincosamide- streptogramin B (MLSB) resistance with resistance to moxifloxacin in Clostridium difficile
    Ackermann, G
    Degner, A
    Cohen, SH
    Silva, J
    Rodloff, AC
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (03) : 599 - 603
  • [4] The macrolide-lincosamide-streptogramin B resistance determinant from Clostridium difficile 630 contains two erm(B) genes
    Farrow, KA
    Lyras, D
    Rood, JI
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (02) : 411 - 413
  • [5] PCR ribotype prevalence and molecular basis of macrolide-lincosamide-streptogramin B (MLSB) and fluoroquinolone resistance in Irish clinical Clostridium difficile isolates
    Solomon, Katie
    Fanning, Seamus
    McDermott, Sinead
    Murray, Sean
    Scott, Louise
    Martin, Alan
    Skally, Mairead
    Burns, Karen
    Kuijper, Ed
    Fitzpatrick, Fidelma
    Fenelon, Lynda
    Kyne, Lorraine
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (09) : 1976 - 1982
  • [6] Prevalence of Inducible Macrolide-Lincosamide-Streptogramin B (MLSB) Resistance in Erythromycin-Resistant Staphylococci
    Kim, Kyung-Hee
    Park, Soon-Ho
    Park, Pil-Whan
    Ahn, Jeong-Yeal
    Seo, Yiel-Hea
    [J]. INFECTION AND CHEMOTHERAPY, 2010, 42 (03): : 171 - 174
  • [7] In vivo spread of macrolide-lincosamide-streptogramin B (MLSB) resistance-A model study in chickens
    Marosevic, D.
    Cervinkova, D.
    Vlkova, H.
    Videnska, P.
    Babak, V.
    Jaglic, Z.
    [J]. VETERINARY MICROBIOLOGY, 2014, 171 (3-4) : 388 - 396
  • [8] Prevalence and association of PCR ribotypes of Clostridium difficile isolated from symptomatic patients from Warsaw with macrolide-lincosamide-streptogramin B (MLSB) type resistance
    Pituch, H
    Brazier, JS
    Obuch-Woszczatnski, P
    Wultanska, D
    Meisel-Mikolajczyk, F
    Luczak, M
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 2006, 55 (02) : 207 - 213
  • [9] Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants
    Roberts, MC
    Sutcliffe, J
    Courvalin, P
    Jensen, LB
    Rood, J
    Seppala, H
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (12) : 2823 - 2830
  • [10] Demonstration of staphylococci with inducible macrolide-lincosamide-streptogramin B (MLSB) resistance in sewage and river water and of the capacity of anhydroerythromycin to induce MLSB
    Hess, Stefanie
    Gallert, Claudia
    [J]. FEMS MICROBIOLOGY ECOLOGY, 2014, 88 (01) : 48 - 59